Home
Home » companies

Orexigen

Will Obesity Drugs Gain Soon?

Will Obesity Drugs Gain Soon?
Motley Fool

Is Orexigen Therapeutics Burning Too Much Cash?

Is Orexigen Therapeutics Burning Too Much Cash?
Motley Fool

Vivus And Anti-Obesity Sector Benefit From New Insurance Deal

Vivus And Anti-Obesity Sector Benefit From New Insurance Deal
Seeking Alpha

Exciting Catalysts Approaching for This Bet

Exciting Catalysts Approaching for This Bet
Motley Fool

Arena Faces A Convergence Of DEA And European Decisions

Arena Faces A Convergence Of DEA And European Decisions
Seeking Alpha

Vivus Seeing Traction With Qsymia

Vivus Seeing Traction With Qsymia
Seeking Alpha

Vivus Gets Restrictions Loosened

Vivus Gets Restrictions Loosened; Will Be Available in Retail Pharmacies Later This Year
Seeking Alpha

How Doctors Actually Diagnose Obesity

How Doctors Actually Diagnose Obesity
Motley Fool

Should Anti-Obesity Drug Company Stocks Trade In Tandem?

Should Anti-Obesity Drug Company Stocks Trade In Tandem?
Seeking Alpha

Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012

Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
Yahoo